Literature DB >> 8757041

Incidence of amyotrophic lateral sclerosis in three counties in western Washington state.

V McGuire1, W T Longstreth, T D Koepsell, G van Belle.   

Abstract

We conducted a population-based study of amyotrophic lateral sclerosis (ALS) in King, Pierce, and Snohomish counties in western Washington state. Between April 1, 1990 and March 31, 1995, neurologists diagnosed 235 patients with ALS, including 127 men (54%) and 108 women (46%). The incidence rate, age-adjusted to the 1990 total U.S. population, was higher for men at 2.1 per 100,000 per year (95% CI, 1.3 to 2.9) than for women at 1.9 (95% CI, 1.1, 2.7) and increased with age for both men and women. These incidence rates are consistent with other studies from northern latitudes.

Entities:  

Mesh:

Year:  1996        PMID: 8757041     DOI: 10.1212/wnl.47.2.571

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  41 in total

Review 1.  Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survival.

Authors:  John D Beard; Freya Kamel
Journal:  Epidemiol Rev       Date:  2014-10-31       Impact factor: 6.222

Review 2.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

Review 3.  ALS drug development: reflections from the past and a way forward.

Authors:  Swati Aggarwal; Merit Cudkowicz
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

Review 4.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

5.  Metabolomic analysis and signatures in motor neuron disease.

Authors:  Steve Rozen; Merit E Cudkowicz; Mikhail Bogdanov; Wayne R Matson; Bruce S Kristal; Chris Beecher; Scott Harrison; Paul Vouros; Jimmy Flarakos; Karen Vigneau-Callahan; Theodore D Matson; Kristyn M Newhall; M Flint Beal; Robert H Brown; Rima Kaddurah-Daouk
Journal:  Metabolomics       Date:  2005       Impact factor: 4.290

Review 6.  From animal models to human disease: a genetic approach for personalized medicine in ALS.

Authors:  Vincent Picher-Martel; Paul N Valdmanis; Peter V Gould; Jean-Pierre Julien; Nicolas Dupré
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

7.  Genome-wide analysis of the heritability of amyotrophic lateral sclerosis.

Authors:  Margaux F Keller; Luigi Ferrucci; Andrew B Singleton; Pentti J Tienari; Hannu Laaksovirta; Gabriella Restagno; Adriano Chiò; Bryan J Traynor; Michael A Nalls
Journal:  JAMA Neurol       Date:  2014-09       Impact factor: 18.302

8.  The PRO-ACT database: design, initial analyses, and predictive features.

Authors:  Nazem Atassi; James Berry; Amy Shui; Neta Zach; Alexander Sherman; Ervin Sinani; Jason Walker; Igor Katsovskiy; David Schoenfeld; Merit Cudkowicz; Melanie Leitner
Journal:  Neurology       Date:  2014-10-08       Impact factor: 9.910

9.  Immunological aspects in amyotrophic lateral sclerosis.

Authors:  Maria Carolina O Rodrigues; Júlio C Voltarelli; Paul R Sanberg; Cesario V Borlongan; Svitlana Garbuzova-Davis
Journal:  Transl Stroke Res       Date:  2012-05-03       Impact factor: 6.829

10.  Incidence of amyotrophic lateral sclerosis in Europe.

Authors:  Giancarlo Logroscino; Bryan J Traynor; Orla Hardiman; Adriano Chiò; Douglas Mitchell; Robert J Swingler; Andrea Millul; Emma Benn; Ettore Beghi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-08-25       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.